evofem biosciences inc shares fell 30 to 77 cents after hours as the company said it plans to sell stock and warrants in a public offering evofem which focuses on products for womens sexual and reproductive health plans to use proceeds for purposes including commercialization activities for phexxi a clinical trial and related development activities